After Today’s Bullish Options Activity, Is Cardiovascular Systems Inc’s Near-Term Analysis Positive?

 After Today's Bullish Options Activity, Is Cardiovascular Systems Inc's Near Term Analysis Positive?

In today’s session Cardiovascular Systems Inc (CSII) registered an unusually high (700) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the November, 2016 call, expecting serious CSII increase. With 700 contracts traded and 244 open interest for the Nov, 16 contract, it seems this is a quite bullish bet. The option with symbol: CSII161118C00022500 closed last at: $1.3 or 23.5% down. About 166,143 shares traded hands. Cardiovascular Systems Inc (NASDAQ:CSII) has risen 128.78% since March 28, 2016 and is uptrending. It has outperformed by 124.06% the S&P500.

Analysts await Cardiovascular Systems Inc (NASDAQ:CSII) to report earnings on November, 2. They expect $-0.19 earnings per share, up 53.66% or $0.22 from last year’s $-0.41 per share. After $-0.15 actual earnings per share reported by Cardiovascular Systems Inc for the previous quarter, Wall Street now forecasts 26.67% negative EPS growth.

Cardiovascular Systems Inc (NASDAQ:CSII) Ratings Coverage

Out of 6 analysts covering Cardiovascular Systems (NASDAQ:CSII), 4 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 67% are positive. Cardiovascular Systems has been the topic of 15 analyst reports since August 6, 2015 according to StockzIntelligence Inc. Bank of America upgraded Cardiovascular Systems Inc (NASDAQ:CSII) on Thursday, August 4 to “Neutral” rating. The stock has “Buy” rating given by Needham on Wednesday, June 29. The firm earned “Underperform” rating on Thursday, October 8 by Bank of America. The stock of Cardiovascular Systems Inc (NASDAQ:CSII) has “Underperform” rating given on Friday, January 22 by Needham. The firm has “Market Perform” rating by Leerink Swann given on Thursday, October 8. The firm has “Buy” rating by Dougherty & Company given on Thursday, October 8. As per Thursday, August 6, the company rating was maintained by Needham. The stock has “Buy” rating given by Needham on Thursday, November 5. The rating was downgraded by Zacks to “Hold” on Monday, August 10. On Friday, April 1 the stock rating was upgraded by Needham to “Buy”.

According to Zacks Investment Research, “Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360° Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360° removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its orbital technology to address the growing market need of providing a safer more effective atherectomy device.”

Insitutional Activity: The institutional sentiment increased to 1.32 in 2016 Q2. Its up 0.42, from 0.9 in 2016Q1. The ratio improved, as 7 funds sold all Cardiovascular Systems Inc shares owned while 30 reduced positions. 15 funds bought stakes while 34 increased positions. They now own 22.60 million shares or 20.49% more from 18.76 million shares in 2016Q1.
Broadfin Cap Limited Liability Company last reported 1.23M shares in the company. Secor L P has 27,006 shares for 0.06% of their US portfolio. Gsa Capital Prns Llp holds 0.02% of its portfolio in Cardiovascular Systems Inc (NASDAQ:CSII) for 21,400 shares. First Republic Management has 0% invested in the company for 13,727 shares. Northern Tru holds 392,063 shares or 0% of its portfolio. Credit Suisse Ag holds 0% or 46,111 shares in its portfolio. Nationwide Fund holds 0% of its portfolio in Cardiovascular Systems Inc (NASDAQ:CSII) for 20,366 shares. Connor Clark Lunn Investment Mgmt has invested 0% of its portfolio in Cardiovascular Systems Inc (NASDAQ:CSII). Plante Moran Financial Lc accumulated 154 shares or 0% of the stock. Vanguard Gru holds 1.28M shares or 0% of its portfolio. First Mercantile Tru, a Tennessee-based fund reported 13,499 shares. Weiss Multi has 14,580 shares for 0.02% of their US portfolio. Pura Vida Invs Ltd Com holds 1.13% of its portfolio in Cardiovascular Systems Inc (NASDAQ:CSII) for 145,289 shares. Moreover, Perkins Cap Management has 2.35% invested in Cardiovascular Systems Inc (NASDAQ:CSII) for 111,600 shares. Wfg Advisors L P accumulated 0.11% or 23,370 shares.

Cardiovascular Systems, Inc. is a medical technology company. The company has a market cap of $781.25 million. The Firm is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. It currently has negative earnings. The Firm develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

CSII Company Profile

Cardiovascular Systems, Inc., incorporated on December 6, 2000, is a medical technology company. The Firm is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Firm develops an orbital atherectomy technology for both peripheral and coronary commercial applications. The Company’s peripheral artery disease (PAD) systems are catheter platforms capable of treating a range of plaque types in leg arteries both above and below the knee. The Company’s products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral.

More notable recent Cardiovascular Systems Inc (NASDAQ:CSII) news were published by: Businesswire.com which released: “Cardiovascular Systems, Inc. Reports Fiscal 2017 First-Quarter Financial Results” on October 26, 2016, also Fool.com with their article: “Why Cardiovascular Systems Inc’s Stock Flatlined Today” published on January 23, 2016, Bizjournals.com published: “Former Cardiovascular Systems CEO David Martin dies at 51” on May 05, 2016. More interesting news about Cardiovascular Systems Inc (NASDAQ:CSII) were released by: Benzinga.com and their article: “Mid-Morning Market Update: Markets Open Higher; Twitter Beats Q3 Expectations” published on October 27, 2016 as well as Prnewswire.com‘s news article titled: “Shareholder Class Action Filed Against Cardiovascular Systems, Inc. – CSII” with publication date: February 18, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment